Ovarian Cancer — Year in Review Series on Relevant New Datasets and Advances
Oncology Today with Dr Neil Love
00:00
Relatuzumab (CDH6) ADC — mechanism and trial plan
Nicoletta reviews the CDH6-targeted ADC, phase results and the all-comer phase III comparing to single-agent chemotherapy.
Play episode from 17:40
Transcript
